Mobilização Feminista, Violência de Gênero e Práticas Judiciais no Brasil: Reflexões à Luz da Teoria dos Sistemas Sociais

The critical feminist theory of law have characterized the Brazilian legal system as refractory with regards to women´s demands and as yet another mechanism that upholds traditional gender archetypes. Recently, the Law 11.340/06 (The Maria da Penha Act) encourages new reflections on legal decisions regarding so-called gender conflicts in Brazil. Influenced by standards laid out in international decrees regarding the women´s rights, this Law introduces innovative elements such as the definition of “gender-based violence”. This study reflects theoretically and empirically on the role of the judicial system in the application of the Law 11.340/06, and discusses how the category gender-based violence is being used by those pertaining to the legal system. The contributions of Niklas Luhmann’s social systems theory are useful to illustrate the understanding of judicial practices and their impact on the realization of the outlooks surrounding efforts focused on the implementation of the Law 11.340/06.A teoria crítica feminista do Direito, no Brasil, aponta o Judiciário como hermético às reivindicações das mulheres, reprodutor dos arquétipos que reforçam a desigualdade de gênero e a discriminação contra as mulheres. A entrada em vigor da lei 11.340/06 (Lei Maria da Penha) fomenta novas reflexões sobre a judicialização dos chamados conflitos de gênero. Dentre os elementos introduzidos pela Lei Maria da Penha, ganha relevância a criação da categoria normativa “violência de gênero”. O presente trabalho reflete teórica e empiricamente o manejo dessa nova categoria normativa pelos operadores do sistema de justiça, num contexto de articulação de serviços e de multidisciplinariedade. As contribuições da teoria dos sistemas sociais proposta por Niklas Luhmann iluminam a reflexão sobre as práticas judiciais nesse contexto.A teoria crítica feminista do Direito, no Brasil, aponta o Judiciário como hermético às reivindicações das mulheres, reprodutor dos arquétipos que reforçam a desigualdade de gênero e a discriminação contra as mulheres. A entrada em vigor da lei 11.340/06 (Lei Maria da Penha) fomenta novas reflexões sobre a judicialização dos chamados conflitos de gênero. Dentre os elementos introduzidos pela Lei Maria da Penha, ganha relevância a criação da categoria normativa “violência de gênero”. O presente trabalho reflete teórica e empiricamente o manejo dessa nova categoria normativa pelos operadores do sistema de justiça, num contexto de articulação de serviços e de multidisciplinariedade. As contribuições da teoria dos sistemas sociais proposta por Niklas Luhmann iluminam a reflexão sobre as práticas judiciais nesse contexto

Confidencialidade de dados em um hospital-escola dedicado à pesquisa

Clinical information derived from medical care is registered in clinical records in physical or electronic files in different hospital institutions dedicated to teaching. This valuable information is a fundamental tool for clinical research; therefore, it should be considered confidential from the moment the patient transfers it, until after the end of their treatment. When members of a hospital-school carry out research activities, they use information contained in clinical records. Confidentiality of these records is protected by law, for this reason, it is necessary to underpin and develop a method to help researchers to learn this clinical data without violating privacy and confidentiality. It is necessary to question ourselves whether a privacy notice indicating patients that the information derived from their conditions may subsequently be used for research purposes will be enough to resolve disputes related to data collection; in this regard, a privacy notice is a legal document used for the protection of people's data; using it in teaching and research hospital institutions will facilitate the use of information derived from consultations and maintain confidence that the data used in research will respect, first and foremost, confidentiality and privacy, through anonymity.La información clínica que deriva de la atención médica es almacenada en los expedientes clínicos que se encuentran en archivos físicos o electrónicos en las distintas instituciones hospitalarias que se dedican a la enseñanza. Esta valiosa información constituye una herramienta fundamental en la investigación clínica, por lo tanto, debe de ser considerada confidencial desde que el paciente la remite hasta después de finalizar su tratamiento. Cuando los miembros de un hospital-escuela realizan actividades de investigación, utilizan la información contenida en los expedientes clínicos. La confidencialidad de estos registros es protegida por la ley, por esta razón es necesario fundamentar y desarrollar un método que ayude a los investigadores a conocer estos datos clínicos sin violar su privacidad y confidencialidad. Es necesario cuestionarnos si un aviso de privacidad que indique a los pacientes que la información derivada de sus padecimientos puede utilizarse posteriormente para fines de investigación será suficiente para resolver los conflictos relacionados con la obtención de datos. Un aviso de privacidad es un documento legal que se utiliza para la protección de datos de las personas, aplicarlo en las instituciones hospitalarias dedicadas a la enseñanza y a la investigación facilitará el uso de la información derivada de las consultas y mantendrá la confianza de que los datos utilizados en la investigación respetarán, la confidencialidad y la privacidad, a través del anonimato.As informações clínicas derivadas dos cuidados médicos são armazenadas nos prontuários médicos encontrados em arquivos físicos ou eletrônicos de diversos hospitais que se dedicam ao ensino. Essas informações valiosas são uma ferramenta fundamental na pesquisa clínica, portanto, devem ser consideradas confidenciais desde o momento em que o paciente as envia até o final do tratamento. Quando os membros de um hospital-escola realizam atividades de pesquisa, eles usam as informações contidas nos registros médicos. A confidencialidade desses registros é protegida por lei, por isso é necessário fundamentar e desenvolver um método que ajude os pesquisadores a conhecer esses dados clínicos sem violar sua privacidade e confidencialidade. É necessário questionar se um aviso de privacidade que informe aos pacientes que as informações derivadas de suas condições podem ser usadas posteriormente para fins de pesquisa será suficiente para resolver disputas relacionadas à coleta de dados. Um aviso de privacidade é um documento legal usado para a proteção de dados de indivíduos. Aplicá-lo em hospitais envolvidos em ensino e pesquisa facilitará o uso de informações derivadas das consultas e manterá a confiança de que os dados usados na pesquisa respeitarão, em primeiro lugar, a confidencialidade e a privacidade, por meio do anonimato

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Una mirada interdisciplinar sobre los retos actuales de la infancia en un mundo globalizado (RETIN)

El concepto de infancia ha ido evolucionando a lo largo de la historia. En el siglo XX, especialmente en sus últimos años, se ha prestado mayor atención al desenvolvimiento de los seres humanos en esta etapa de la vida, atención que se ha concretado, entre otras cuestiones, en el interés creciente hacia los derechos de la infancia. En 1989 este proceso se ve reforzado por la aprobación de la Convención de las Naciones Unidas sobre los Derechos de los niños y las niñas, que reconoce a las personas menores de 18 años de edad derechos civiles, sociales, económicos, culturales y políticos, derechos de ciudadanía en suma para el colectivo infantil, considerado previamente como puro objeto de protección. En el ámbito de las ciencias sociales se ha producido también una transformación. Desde un enfoque sociológico se considera que la infancia es un espacio temporal en la trayectoria de vida de las personas, y también el espacio social definido para el desarrollo de la vida de los niños. Se reconoce que también los niños, como grupo social, no sólo pueden actuar, sino que actúan de hecho, y se relacionan con los demás grupos sociales, modificando, construyendo y contribuyendo a los cambios que se producen en la sociedad. En este marco, el objetivo del presente proyecto es la elaboración y difusión de materiales audiovisuales pedagógicos basados en entrevistas sobre los retos actuales de la infancia en un mundo globalizado, como son: cuidados en la ciudad, infancia migrante no acompañada, desigualdades socioeconómicas, nuevas tecnologías y género

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

Analysis of shared heritability in common disorders of the brain

ience, this issue p. eaap8757 Structured Abstract INTRODUCTION Brain disorders may exhibit shared symptoms and substantial epidemiological comorbidity, inciting debate about their etiologic overlap. However, detailed study of phenotypes with different ages of onset, severity, and presentation poses a considerable challenge. Recently developed heritability methods allow us to accurately measure correlation of genome-wide common variant risk between two phenotypes from pools of different individuals and assess how connected they, or at least their genetic risks, are on the genomic level. We used genome-wide association data for 265,218 patients and 784,643 control participants, as well as 17 phenotypes from a total of 1,191,588 individuals, to quantify the degree of overlap for genetic risk factors of 25 common brain disorders. RATIONALE Over the past century, the classification of brain disorders has evolved to reflect the medical and scientific communities' assessments of the presumed root causes of clinical phenomena such as behavioral change, loss of motor function, or alterations of consciousness. Directly observable phenomena (such as the presence of emboli, protein tangles, or unusual electrical activity patterns) generally define and separate neurological disorders from psychiatric disorders. Understanding the genetic underpinnings and categorical distinctions for brain disorders and related phenotypes may inform the search for their biological mechanisms. RESULTS Common variant risk for psychiatric disorders was shown to correlate significantly, especially among attention deficit hyperactivity disorder (ADHD), bipolar disorder, major depressive disorder (MDD), and schizophrenia. By contrast, neurological disorders appear more distinct from one another and from the psychiatric disorders, except for migraine, which was significantly correlated to ADHD, MDD, and Tourette syndrome. We demonstrate that, in the general population, the personality trait neuroticism is significantly correlated with almost every psychiatric disorder and migraine. We also identify significant genetic sharing between disorders and early life cognitive measures (e.g., years of education and college attainment) in the general population, demonstrating positive correlation with several psychiatric disorders (e.g., anorexia nervosa and bipolar disorder) and negative correlation with several neurological phenotypes (e.g., Alzheimer's disease and ischemic stroke), even though the latter are considered to result from specific processes that occur later in life. Extensive simulations were also performed to inform how statistical power, diagnostic misclassification, and phenotypic heterogeneity influence genetic correlations. CONCLUSION The high degree of genetic correlation among many of the psychiatric disorders adds further evidence that their current clinical boundaries do not reflect distinct underlying pathogenic processes, at least on the genetic level. This suggests a deeply interconnected nature for psychiatric disorders, in contrast to neurological disorders, and underscores the need to refine psychiatric diagnostics. Genetically informed analyses may provide important "scaffolding" to support such restructuring of psychiatric nosology, which likely requires incorporating many levels of information. By contrast, we find limited evidence for widespread common genetic risk sharing among neurological disorders or across neurological and psychiatric disorders. We show that both psychiatric and neurological disorders have robust correlations with cognitive and personality measures. Further study is needed to evaluate whether overlapping genetic contributions to psychiatric pathology may influence treatment choices. Ultimately, such developments may pave the way toward reduced heterogeneity and improved diagnosis and treatment of psychiatric disorders

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

Background Suicide is a leading cause of death worldwide, and nonfatal suicide attempts, which occur far more frequently, are a major source of disability and social and economic burden. Both have substantial genetic etiology, which is partially shared and partially distinct from that of related psychiatric disorders. Methods We conducted a genome-wide association study (GWAS) of 29,782 suicide attempt (SA) cases and 519,961 controls in the International Suicide Genetics Consortium (ISGC). The GWAS of SA was conditioned on psychiatric disorders using GWAS summary statistics via multitrait-based conditional and joint analysis, to remove genetic effects on SA mediated by psychiatric disorders. We investigated the shared and divergent genetic architectures of SA, psychiatric disorders, and other known risk factors. Results Two loci reached genome-wide significance for SA: the major histocompatibility complex and an intergenic locus on chromosome 7, the latter of which remained associated with SA after conditioning on psychiatric disorders and replicated in an independent cohort from the Million Veteran Program. This locus has been implicated in risk-taking behavior, smoking, and insomnia. SA showed strong genetic correlation with psychiatric disorders, particularly major depression, and also with smoking, pain, risk-taking behavior, sleep disturbances, lower educational attainment, reproductive traits, lower socioeconomic status, and poorer general health. After conditioning on psychiatric disorders, the genetic correlations between SA and psychiatric disorders decreased, whereas those with nonpsychiatric traits remained largely unchanged. Conclusions Our results identify a risk locus that contributes more strongly to SA than other phenotypes and suggest a shared underlying biology between SA and known risk factors that is not mediated by psychiatric disorders.Peer reviewe

Robust estimation of bacterial cell count from optical density

Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals &lt;1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data